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Aim of the work: The aim of the study was to assess the occurrence of OSAHS in Egyptian
patients with tachyarrhythmia, and to describe characteristics of patients with concomitant OSAHS
and tachyarrhythmia.
Methods: We enrolled 32 patients with tachyarrhythmia. In addition to standard examination,
investigations and echocardiography to exclude possible causes for arrhythmia all patients under-
went an over-night sleep study (level III) to diagnose OSAHS. Manual scoring was performed by
two specialists according to criteria established by the American Academy of Sleep Medicine
2012. We considered AHI of 15/h as a cutoff point for diagnosing OSAHS.
Results: Of the 32 patients: seventeen had rapid atrial ﬁbrillation (AF), eight had premature ven-
tricular contractions, ﬁve had persistent sinus tachycardia and three had paroxysmal supraventric-
ular tachycardia. OSAHS was present in 27 patients (84.4%), three patients of them had obesity
hypoventilation also. Dividing OSAHS patients according to the disease severity showed that mod-
erate OSAHS in 29.6% patients, and severe OSAHS in 70.4% patients. Studying characteristics of
patients with OSAHS revealed that the mean ± SD of neck circumference (NC) was 39.9
± 2.47 cm, BMI was 36.3 ± 9.17 kg/m2, Waist/hip ratio was 0.91 ± 0.08, Epworth Sleepiness
Scale (ESS) was 10.85 ± 4.5, Mallampati score (MS) was 2.11 ± 0.84, clinical apnea score was
2.8 ± 1.5, and STOP BANG score was 4.03 ± 1.99. Apnea hypopnea index (AHI) was 49.3
± 33.2, oxygen desaturation index [3%] (ODI) was 39.9 ± 31, mean O2 saturation was 93.6
± 8.84 and minimal O2 saturation was 7.9 ± 14.49. Nocturnal bradytachyarrhythmia was found
in most of patients, the minimal pulse rate during sleep ranges from 22 to 82/min while the maximalfailure,
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Egypt. J. Chest Dis. Tuberc. (2016), http://dpulse rate ranges from 77 to 254/min. Both AHI and ODI were found to be signiﬁcantly directly
correlated with each of BMI, NC, waist/hip ratio, clinical apnea score, STOP BANG score, ESS,
MS and mean pulse rate. Linear regression analysis of potential predictors of increased apnea
hypopnea index revealed that triglyceride level is the highest predictor followed by NC then BMI.
Conclusions: OSAHS is highly prevalent in patients with tachyarrhythmia. High triglyceride, NC
and BMI are the most predictors of presence of OSAHS. AF is the most common form of the
arrhythmia in patients with OSAHS.
Clinical implications: OSAHS should be considered as part of the workup of patients with tach-
yarrhythmia. Both clinical apnea score and STOP BANG are good screening questionnaire to
choose patients who need sleep study.
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Cardiac tachyarrhythmias are important epidemiological and
public health problems as they are signiﬁcantly associated with
increased risks of cardiovascular complications and sudden
death [1], consequently leading to decreased quality of life, dis-
ability, high mortality, and healthcare expense [2].
Obstructive sleep apnea hypopnea syndrome (OSAHS) is
the most common variant of SRBD. It affects 3–7% of men
and 2–5% of women in the general adult population. Although
OSAHS is a common disabling syndrome, yet it is still under-
diagnosed [3].
Obstructive sleep apnea hypopnea syndrome has been
implicated in the pathogenesis of many cardiovascular diseases
[4]. Over the last decade, the association between OSAHS and
cardiac rhythm disorders has garnered the attention of cardiol-
ogists and researchers from different clinical subspecialties [5].
Tachyarrhythmias are presumed to be a common problem
in patients with OSAHS. It is hypothesized that tachyarrhyth-
mias can also occur in OSAHS even in the absence of heart
failure and structural heart diseases [6]. The notion that
OSAHS may originate tachyarrhythmia is attractive, but
unfortunately the incidence and prevalence of SRBD in
patients with tachyarrhythmia is poorly deﬁned, in part due
to smaller number of studies and also the fact that the two con-
ditions share many of the same risk factors, such as age, obe-
sity, male sex, hypertension, coronary disease, and heart
failure, makes it difﬁcult to control potential confounders
and to establish a clear independent causal relationship
between them [7].
Aim of the work
To study the occurrence of OSAHS in Egyptian patients with
tachyarrhythmia, and to describe characteristics of patients
with concomitant OSAHS and tachyarrhythmia.
Subjects and methods
Study population and subjects
Study population included thirty-two patients with tach-
yarrhythmia diagnosed on the basis of current American Col-
lege of Cardiology, American Heart Association, and
European Heart Society guidelines. Patients were enrolled overet al., Occurrence of sleep related breat
x.doi.org/10.1016/j.ejcdt.2016.09.00518 months (April 2012–Sept 2013) from Maamoura Chest
Hospital, Alexandria University Hospital, Kom Alshokafa
Hospital and Alexandria petroleum Hospital.
Inclusion was not based on any clinical suspicion of under-
lying SRBD, patients were selected irrespective of age, gender
or BMI. We excluded patients with structural heart diseases,
LVEF < 50%, myocarditis, pericarditis and patients with
acute coronary insult. We also excluded patients with arrhyth-
mia due to a transient or reversible cause and drug induced
tachyarrhythmia.
The study protocol was approved by the local ethics com-
mittee, and informed consents were obtained.
Study measurements
Critical care specialists had examined all patients as regards to
clinical examination, ECG monitoring, echocardiography,
plain chest x-rays and laboratory results. All patients were
on anti-arrhythmic drugs.
All patients were subjected to the following
1. History taking including symptoms related to tach-
yarrhythmia and its possible causes, in addition to compre-
hensive sleep related complains and questionnaire including
Epworth Sleepiness Scale [8], STOP BANG questionnaire:
[9] and Clinical apnea score [10].
2. Full clinical examination including Mallampati score.
3. Anthropometric measurements including: Body mass index
(BMI) [11], Neck circumference (NC), and Waist/hip ratio
(WHR)
4. In addition to routine laboratory investigations arterial
blood gases and lipid proﬁle were assessed.
5. Sleep Study: Cardio respiratory screening (polygraph)
using level 3 device (Sleep Test-Polymate YH-1000 Sleep
Screener). We used a portable screener which helps to elim-
inate the ﬁrst night fear and make the patient more
comfortable.
The polymate sleep screener device evaluates: (a) Nasal air-
ﬂow via a nasal cannula attached to a small case that houses a
pressure transducer. (b) Arterial oxygen saturation and pulse
rate measured using ﬁnger pulse sensor and pulse oximeter.
(c) Snoring via a microphone attached to the device. (d) Body
position through abdominal belt containing a built-in sensor
for body position. (e) Chest and abdominal movement via
two chest leads and two abdominal leads.hing disorders in Egyptian patients with tachyarrhythmia without heart failure,
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hypopneas scored using criteria established by the American
Academy of Sleep Medicine 2012. [12] Apnea was considered
when there is drop in the ﬂow excursion byP90% of baseline
for at least ten seconds and hypopnea was deﬁned when there
is drop byP30% of baseline and associated withP3% desat-
uration from pre-event baseline for at least 10 s. Obstructive
apnea was scored if apnea is associated with continued inspira-
tory effort throughout the entire period of absent airﬂow and
Central apnea was scored if it is associated with absent inspi-
ratory effort throughout the entire period of absent airﬂow
while Mixed apnea is considered if the apnea starts as a central
event and then becomes obstructive during the latter portion
of the same episode. Obstructive hypopnea was considered if
associated with either of snoring, ﬂow limitation or paradoxi-
cal movement of the respiratory muscles while central hypop-
nea is considered if all of the three criteria were absent.
Hypoventilation was considered when there was sustained
decrease of SpO2 as detected by the oximeter (sagging of the
oximetric tracing) while the patient is on room air and not
receiving any supplemental oxygen [13].
The following parameters were calculated: Apnea hypopnea
index (AHI), baseline O2 saturation, mean O2 saturation, min-
imal O2 saturation, oxygen desaturation index 3% (ODI 3%),
90%, and snoring index. Also minimal pulse rate, maximum
pulse rate and average pulse rate.
Clinically, OSAHS is deﬁned by the occurrence of daytime
sleepiness, loud snoring, witnessed breathing interruptions, or
awakenings due to gasping or choking in the presence of at
least 5 obstructive respiratory events (apneas, hypopneas or
respiratory effort related arousals) per hour of sleep. The pres-
ence of 15 or more obstructive respiratory events per hour of
sleep in the absence of sleep related symptoms is also sufﬁcient
for the diagnosis of OSAHS due to the greater association of
this severity of obstruction with important consequences such
as increased cardiovascular disease risk [14].
Statistical analysis
The raw data were coded and transformed into coding sheets.
The results were checked. Then, the data were entered into
SPSS system ﬁles (SPSS package version 18) using personal
computer. Analysis and interpretation of data were conducted.
Exploration of the data yielded:
(a) Complete descriptive statistics including the minimum
and maximum, range, mean, median and inter-quartile
range for each variable.
(b) Normality test was performed and as all variables
resulted in insigniﬁcant Kolmogorov–Smirnov (KS) so,
normally distributed variables were analyzed using para-
metric analysis.Please
Egypt. Data were described using minimum, maximum, m-
ean and standard deviation.
 Box and Whiskers graph was used in all variables
regardless of normality.
 Parametric correlation using Pearson’s correlation
was used.(c) Logistic regression analysis was done to predict patients
with tachyarrhythmia and OSAHS. Different studiedcite this article in press as: S. Mourad et al., Occurrence of sleep related breat
J. Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.005parameters were measured. All predictor variables were
initially entered into this analysis as continuous vari-
ables then the backward conditional analysis was
performed.
Results
The present study was carried out on randomly selected (irre-
spective of age and gender) thirty-two patients with tach-
yarrhythmia of unknown etiology.
Electrocardiogram characteristics
According to ACC/AHA guidelines [15] the following types of
arrhythmia have been encountered: Seventeen patients had
rapid atrial ﬁbrillation. (2 had paroxysmal, 1 had persistent
and 14 had permanent AF), eight patients had premature ven-
tricular contractions (one had bigeminy and 7 had multifocal),
ﬁve patients had persistent sinus tachycardia and three patients
had paroxysmal supraventricular tachycardia (case 14 had
both rapid AF and multifocal PVCs).
According to symptoms and sleep study the patients were divided
into two groups (Fig. 1)
Group I (OSAHS patients)
27 patients with AHI P15/hr. (84.4%): Eight patients had
moderate OSAHS and nineteen patients had severe OSAHS;
three of those patients had OHS in addition.
Group II: Five patients did not fulfill the criteria of OSAHS
diagnosis
Two had AHI <5/hr and three had AHI from 5–15/hr in the
absence of sleep related complaints.
Due to the very small sample size of group II patients
(n= 5) which implies low statistical signiﬁcance, comparison
and parametric correlations were done in group I patients
only.
Table 1 shows the results of demographic, anthropometric
data, different scores and scales examined, presence or absence
of related cardiovascular and metabolic disorders and labora-
tory investigations in the studied patients.
Regarding types of tachyarrhythmias in patients of group I,
thirteen patients were admitted due to AF; eleven of them were
having permanent AF, one persistent and one paroxysmal AF.
Five patients suffer from sinus tachycardia, seven patients suf-
fer from multifocal premature ventricular contractions and
three patients suffer from paroxysmal supraventricular tachy-
cardia. Patient number 14 was suffering from both Paroxysmal
AF and M.PVCs
Table 2 shows the sleep study and arterial blood gases data
in both groups. Apnea hypopnea index and ODI3% values
were presented in box plot diagram (Fig. 2). Also minimal,
mean and maximal heart rates during sleep are presented in
Fig. 3. Using the OSAHS severity classiﬁcation which is
deﬁned as mild for AHI P5/h and <15/h, moderate for
AHI P15/h and 630/h, severe for AHI >30/h, [24] None
was diagnosed as having mild OSAHS, eight had moderate
OSAHS (29.6%), 19 had severe OSAHS (70.4%), (Fig. 1) threehing disorders in Egyptian patients with tachyarrhythmia without heart failure,
Figure 1 Pie chart: the prevalence of sleep related breathing disorders in the studied patients.
Table 1 Demographic, anthropometric data, different scores and scales examined, presence of related cardiovascular and metabolic
disorders and laboratory investigations in the studied patients.
Variable Group I Group II
Mean ± SD Min–max Mean ± SD Min–max
Age (years) 44.2 ± 10 24–65 33 ± 6.63 24–39
Sex (Male: Female) (ratio) 1:2 2:3
BMI 36.39 ± 9.1 22.8–59 27.2 ± 6.01 22.4–35.7
Neck circumference 39.9 ± 2.47 35–45 35.4 ± 1.67 34–38
Waist/Hip ratio 0.92 ± 0.08 0.74–1.12 0.78 ± 0.076 0.66–0.84
Smoking status
Ex-smoker (n) 2 1
Non smoker (n) 25 4
Mallampati score 2.11 ± 0.84 1–4 1 1
Epworth Sleepiness Scale 10.85 ± 4.528 5–24 5.6 ± 1.67 3–7
Clinical Apnea Score 2.11 ± 0.8417 0–4 0.4 ± 0.54 0–1
STOP BANG 4.03 ± 1.992 4.03 ± 1.99 0.6 ± 0.54 0–1
Other related disorder
Hypertension (n) 12 0
Ischemic heart disease (n) 7 1
Pulmonary hypertension (n) 2 0
Diabetes Mellitus (n) 12 0
Metabolic syndrome (n) 16 0
Serum Cholesterol 181.9 ± 31.1 120–260 127.6 ± 40.7 80–170
Serum Triglycerides 169.7 ± 47.3 100–274 115 ± 14.8 102–140
Fasting Blood Glucose 153.5 ± 94.6 80–403 86.6 ± 11.8 77–106
M: male; F: female; NS: never-smoker; XS: ex-smoker; BMI: body mass index; NC: Neck circumference; W/H ratio: waist/hip ratio, n: number
of patients.
4 S. Mourad et al.of the patients with severe OSAHS had obesity hypoventila-
tion syndrome in addition. None of the included patients
had central sleep apnea.
Linear correlation between different studied parameters
measured for patients of group I revealed the following statis-
tically signiﬁcant correlations:
Both body mass index and neck circumference were corre-
lated directly with each of apnea hypopnea index, (AHI)
[p= 0.018 and <0.0001] (Figs. 4 and 5 respectively), oxygen
desaturation index (ODI) [p= 0.011 and < 0.0001], baseline
oxygen saturation [p= 0.009 and 0.045], mean oxygen satura-
tion [p= 0.008 and 0.014], minimal oxygen saturationPlease cite this article in press as: S. Mourad et al., Occurrence of sleep related breat
Egypt. J. Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.005[p= 0.004 and 0.010], and t90 [p=<0.0001 and 0.002].
AHI was correlated directly with each of mean pulse rate dur-
ing sleep [p= 0.002], serum cholesterol [p= 0.004], triglyc-
erides [p< 0.0001] (Fig. 6), and fasting blood glucose
[p< 0.0001].
Linear regression analysis of potential predictors of increased
apnea hypopnea index in the studied patients with
tachyarrhythmia
Stepwise regression analysis was performed. Predictors entered
in model are age, BMI, NC, Serum TG, Diastolic BP, Mini-hing disorders in Egyptian patients with tachyarrhythmia without heart failure,
Table 2 The sleep study and arterial blood gases data in studied patients.
Variable Group I Group II
Mean ± SD Min–Max Mean ± SD Min–Max
AHI n/h 49.3 ± 33.2 15–133 7.4 ± 2.8 2.3–10.8
Baseline O2 saturation (%) 93.6 ± 6.36 65–99% 96.2 ± 0.83 95–97
Mean O2 saturation (%) 93.6 ± 8.84 65–97% 95.4 ± 0.54 95–96
Minimal O2 saturation (%) 77.9 ± 14.49 31–93% 96.2 ± 0.83 95–97
ODI (4%) n/h 28.4 ± 32.13 2.4–110 3.2 ± 1.73 1.8–5.5
ODI (3%) 39.9 ± 31 8–120 4.5 ± 2.71 2.1–5.7
T90% (%) 11.1 ± 26.7 0–100% 0.1 ± 0.1 0–0.2
Snoring index 247.3 ± 294 5–927 24.8 ± 20.5 5–50.8
Minimum pulse rate 43.3 ± 13.9 22–82 43.8 ± 9.6 35–60
Maximum pulse rate 115.7 ± 37.8 77 – 254 100.4 ± 6.9 92–108
Mean pulse rate 77.7 ± 15.3 45–111 78.4 ± 4.3 72–83
pH 7.37.6 ± 0.02 7.32–7.42 7.4 ± 0.014 7.39–7.42
PaCO2 mmHg 42.8 ± 7.2 37–68 43.5 ± 7.2 37–45
PaO2 mmHg 88.8 ± 12.9 46–99 95 ± 2.82 92–98
HCO3 mEq/L 25 ± 3.3 22–36 24.1 ± 0.4 23–24
Figure 2 Box plot: apnea hypopnea index and oxygen desatu-
ration Index 3% in OSAHS patients.
Figure 3 Maximum, mean and minimum pulse rate during sleep
in OSAHS patients.
Figure 4 Correlation between Body mass index and apnea
hypopnea index in OSAHS patients.
Figure 5 Correlation between neck circumference and apnea
hypopnea index in OSAHS patients.
Occurrence of sleep related breathing disordersin Egyptian patients with tachyarrhythmia without heart failure 5mum pulse rate, Mean pulse rate. Three models were carried
out and we adopted model ‘‘3”. Partial correlation proved
there is no multicollinearity (r never exceed 0.850). Residual
errors proved to be independent (Durbin Watson = 2.104).
Multiple regression analysis was used to develop a model to
predict the presence of OSAHS in patients with tachyarrhyth-Please cite this article in press as: S. Mourad et al., Occurrence of sleep related breat
Egypt. J. Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.005mia. Each of the predictor variables entered in the multiple
regression analysis had a signiﬁcance of p< 0.01. We adopted
three models of which model ‘‘3” (BMI + NC+ serum
triglycerides) yielded the highest predictive value (r2 = 0.886,
adjusted r2 = 0.871, std error = 9.83). Multiple regression
analysis results suggest that patients with tachyarrhythmiahing disorders in Egyptian patients with tachyarrhythmia without heart failure,
Figure 6 Correlation between apnea hypopnea index and serum
triglycerides in OSAHS patients.
6 S. Mourad et al.who have higher BMI, NC and triglycerides values are more
likely to have underlying OSAHS (Table 3).
Discussion
In the present study we examined 32 patients, admitted to the
hospital due to tachyarrhythmia, for presence of obstructive
sleep apnea. Only 5 patients (15.6%) didn’t fulﬁll the criteria
for diagnosing OSAHS, while 27 patients (84.4%) were diag-
nosed as having OSAHS.
Other studies have evaluated the potential independent
relationship between OSAHS and cardiac tachyarrhythmia.
The ﬁrst report was published in 2004 by Porthan et al. [16]
who studied the prevalence of sleep apnea syndrome in 59
patients with lone AF. They found that the prevalence of sleep
apnea syndrome in the AF group was 32%, which did not dif-
fer much from that in the control subjects (29%, p= 0.67).
The previous study was soon contradicted by Gami et al.
[17] who prospectively assessed the risk of OSAHS (using Ber-
lin questionnaire) in 2 groups of patients, group I included 151
patients with AF who were referred for cardioversion, while
group II is the general cardiology group (with no past or cur-
rent AF) and those included 373 patients. Both groups had sta-
tistically similar gender distribution, age, body mass index, and
rates of diabetes, hypertension, and congestive heart failure.
OSAHS was signiﬁcantly higher in the AF group than in the
general cardiology group (49% versus 32%, P= 0.0004).
Braga et al. [18] evaluated SRBD – using polysomnography
– in 52 chronic AF patients 32 control. Considering a cut-off
value for AHIP10/h of sleep, the AF group had a higher fre-
quency of OSAHS compared to the control group (81.6% ver-
sus 60%, p = 0.03).
Stevenson et al. [19] investigated the prevalence of SRBD in
90 patients with paroxysmal or permanent AF and comparedTable 3 Correlation Coefﬁcients.
Model 3 Unstandardized coeﬃcients
B Std. Error t
(Constant) 194.884 42.6594 4.5683
TG 0.325 0.0 4.178
NC 5.137 1.436 3.576
BMI 0.633 0.285 2.219
Please cite this article in press as: S. Mourad et al., Occurrence of sleep related breat
Egypt. J. Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.005this with 45 control patients who had cardiac arrhythmia other
than atrial ﬁbrillation. The proportion of patients with signif-
icant SRBD (AHI >15/h) was signiﬁcantly higher in the AF
group than in the control population (62% versus 38% respec-
tively, P= 0.01). Apnea hypopnea index in AF patients was
higher than in controls (23.19 ± 19.26 versus 14.66 ± 12.43,
P = 0.01) [19].
In 2009, Bitter et al. [20] investigated the prevalence of sleep
disordered breathing in 150 patients with AF and normal sys-
tolic left ventricular function. SRBD was documented in 74%
of all patients with AF (43% had OSAHS and 31% had CSA/
CSB) [20].
Comparing our results with the results of the previously
mentioned studies, we ﬁnd that the prevalence of OSAHS in
patients with tachyarrhythmia is higher in the present study.
This may be related to higher BMI values in our patients or
because we included all types of tachyarrhythmia. However,
if we excluded non-AF patients and included only patients
with AF, the proportion of patients with OSAHS would be
76% (13 out of 17 patients) which is comparable with Steven-
son, Bitter and Braga et al. results.
Another explanation for the higher prevalence of OSAHS
in the present study may be related to the new rules of manual
scoring we used [12]. We considered hypopnea when there was
onlyP3% desaturation in association withP30% decrease in
the amplitude of the airﬂow which may lead to increase in
hypopnea index.
Although Porthan et al. results showed no difference
between AF group and control group, yet results did ﬁnd a
high prevalence of sleep apnea syndrome in patients with lone
AF (32% had sleep apnea syndrome). One would presume that
our results are higher because we did not exclude patients with
hypertension, ischemic heart disease nor diabetes. This
assumption was taken into consideration, and we found that
if we excluded patients who were either hypertensive, ischemic
or diabetic, 10 patients out of 14 (71%) have OSAHS. Also a
limitation in Porthan et al. study is that the control group was
derived from respondents to a letter, 43% of which were not
answered. As other authors point out [19]; this raises the pos-
sibility of bias in the control group toward those with
symptoms.
In 2015, Lavergne et al. concluded that inclusion of SDB
recognition and management strategies as part of AF manage-
ment appears to have the potential to reduce the impact of this
arrhythmia at both the individual and societal levels, and it
should be recognized as important in recent guidelines [21].
In the present study, sixteen patients had tachyarrhythmia
other than AF; ﬁfteen of those patients (93.7%) had OSAHS;
seven out of eight patients with PVCs had OSAHS, all patients
with chronic sinus tachycardia and paroxysmal supraventricu-
lar tachycardia were diagnosed as having OSAHS.95% Conﬁdence interval for B
Sig. Lower bound Upper bound
0.000 283.354 106.414
0.000 0.163 0.486
0.0016 2.1582 8.117
0.037 1.224 0.041
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the prevalence of SRBD in patients with severe ventricular
arrhythmias and normal LV systolic function. They found that
60% had SRBD with AHI P10/h, and 34% had moderate to
severe SRBD, with an average AHI of 33.6 ± 16.6/h. Central
dominant sleep apnea was evident in 3 patients with SRBD.
The results of the present study suggest a link between
OSAHS and both AF and non AF tachyarrhythmia. Some
authors speculated that oxygen desaturation accompanied by
surge in arterial blood pressure and sympathetic nerve activity,
which attain levels observed during waking is responsible for
these arrhythmias. [23,24]. In a previous study [25] we found
that urinary norepinephrine was signiﬁcantly higher in early
morning samples than sample derived before sleep in OSAHS
patients suffering from cardiac arrhythmia, and that nore-
pinephrine levels were decreased signiﬁcantly in samples
derived while the patients were using CPAP.
Whether it is the acute effects of respiratory events or the
chronic structural changes resulting from OSA that cause
recurrent atrial ﬁbrillation may have important therapeutic
implications. If it is the former, speciﬁc treatment of OSA with
CPAP or any other effective therapy may be needed to reduce
risk of recurrence. While if it is the autonomic effects of acute
apneic events that trigger recurrent atrial ﬁbrillation, there
may be effective alternatives to prevent OSA-related recur-
rence using pharmacologic modalities, renal sympathetic den-
ervation, or modiﬁcation of the ablation procedure.
Many studies – in a reverse way – have investigated the
prevalence of cardiac arrhythmia in patients with OSAHS
[26,27]. As early as 1983, Guilleminault et al. [26] studied
the occurrence of cardiac arrhythmia in 400 patients with
OSAHS. Results showed that 19% of OSAHS patients had
frequent PVCs and 2% had sustained ventricular tachycardia,
while brady-arrhythmias, sinus arrest and second degree heart
block were found in 18%, 11% and 8% of patients,
respectively.
None of the patients included in the present study had cen-
tral sleep apnea (CSA), this is mostly due to the prior exclusion
of congestive heart failure as a potential cause for arrhythmia.
Likewise, Stevenson et al. [19] who studied SRBD in AF with
normal LVEF and found that CSA was zero%.
However, Bitter et al. results [20] showed an increased
prevalence of CSA/CSB (31.3%) in patients with AF and nor-
mal global systolic LVF. Also Koshino et al. [22] found evi-
denced CSA in 3 out of 35 patients with ventricular
tachyarrhythmia and normal LVEF.
‘‘Is sleep apnea a primary etiologic factor for the development
of arrhythmia?” This question is fundamental in the ﬁeld of
‘‘sleep apnea-related cardiovascular diseases”. In the present
study, the former question motivated us to exclude – so did
previously mentioned studies - possible cofounders that might
cause arrhythmia. Yet, it is difﬁcult to control common risk
factors particularly obesity. These practical constraints had
led to more rigorous study of the assumed ‘independent” rela-
tionship between OSAHS and tachyarrhythmia, directly and
indirectly (by studying the effect of OSAHS treatment on car-
diac arrhythmia).
Camen et al. [28] examined the effects of ‘‘simulated”
obstructive apnea and hypopnea on arrhythmic potential in
41 healthy volunteers. ECG was continuously recorded prior,
during and after simulated obstructive hypopnea (inspiration
through a threshold load), simulated apnea (Mueller maneu-Please cite this article in press as: S. Mourad et al., Occurrence of sleep related breat
Egypt. J. Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.005ver), end-expiratory central apnea and normal breathing in
randomized order. The number of subjects with premature
beats was signiﬁcantly higher during inspiration through a
threshold load (n= 7), and the Mueller maneuver (n = 7)
compared to normal breathing (n= 0) (p= 0.008 for all com-
parisons), but not during end-expiratory central apnea (n= 3,
p= 0.125) [28].
Also, Monahan et al. [29] evaluated respiratory distur-
bances as potential triggers for arrhythmia in those with
SRBD. Overnight polysomnograms from the Sleep Heart
Health Study (n= 2816) were screened for paroxysmal atrial
ﬁbrillation and non sustained ventricular tachycardia (NSVT).
The main ﬁnding of this study is the nearly 18-fold increase in
the relative risk of nocturnal arrhythmia following a respira-
tory disturbance in individuals with a broad range of SRBD
severity (OR 17.5; 95% CI 5.3–58.4) compared to the odds
of an arrhythmia occurring following normal breathing. These
results support a direct temporal link between SRBD events
and the development of these arrhythmias [29].
Likewise, in an indirect way, the effect of CPAP treatment
on cardiac rhythm disturbance had been studied. In a previous
study [25] we found that nocturnal supraventricular and ven-
tricular ectopics were evident in patients with OSAHS which
were abolished almost completely while using CPAP therapy.
Also CPAP increased the minimal heart rate while the maxi-
mal heart rate decreased signiﬁcantly than patients without
CPAP, this showed that the bradytachyarrhythmias usually
associating respiratory events decreased or abolished while
using CPAP.
Neilan et al. [30] found that therapy with CPAP is associ-
ated with lower blood pressure, atrial size, and ventricular
mass, and a lower risk of AF recurrence after pulmonary vein
isolation. Sumi et al. [31] in his study found that CPAP
decreases heart rate in OSAHS patients and Kanagala et al.
[32] found that the recurrence rate of AF at 12 months after
cardioversion was 82% in untreated OSAHS compared to
42% in treated OSAHS patients and 53% in patients without
OSAHS (control group) (p= 0.013).
On 2015 a meta-analysis study systematically reviewed the
published reports on CPAP use and risk of AF. A total of 8
studies on OSA were identiﬁed with 698 CPAP users and
549 non-CPAP users. In metaregression analysis, beneﬁts of
CPAP were stronger for younger, obese, and male patients
(p< 0.05). An inverse relationship between CPAP therapy
and AF recurrence was observed. Results suggest that more
patients with AF should be tested for OSA [33].
In the present study, all OSAHS patients were moderate to
severe, 8 patients (29.5%) had AHI of 15–30/h, 12 patients
(44.5%) had AHI of 30–60/h and 7 patients (26%) had AHI
>60/h. three of the patients with severe OSAHS had obesity
hypoventilation syndrome in addition.
In accordance with our results,Mehra et al. [34] found that
increasing severity of sleep-disordered breathing, as deter-
mined by increasing quartiles of the respiratory disturbance
index (RDI), was associated with increased odds of AF (OR
2.15) and complex ventricular ectopy (CVE) (OR 1.43) com-
pared with the lowest quartile. Mehra et al. also discovered
that different types of sleep apnea were associated with distinct
kinds of arrhythmias: an increasing obstructive sleep apnea
quartile was signiﬁcantly associated with increasing CVE but
not AF while central sleep apnea was more strongly associated
with AF (OR 2.69) than CVE (OR 1.27) [34].hing disorders in Egyptian patients with tachyarrhythmia without heart failure,
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cardiac arrhythmias rose along with the increase in AHI.
These results advance our understanding of the relationship
between daytime tachyarrhythmia and severity of OSAHS.
Some researchers found that arrhythmias caused by mild sleep
disordered breathing are rare, even among patients with other
potentially arrhythmogenic factors such as disabling angina,
and that the prevalence of tachyarrhythmia increases as
OSAHS indices worsen [36]. We can explain this by the persis-
tence of sympathetic overdrive during the day in subjects hav-
ing severe OSAHS. Narkiewicz and Somers [37] postulated
that several neural and humoral mechanisms may contribute
to maintenance of higher sympathetic activity and blood pres-
sure. These mechanisms include chemoreﬂex and baroreﬂex
dysfunction, altered cardiovascular variability, vasoconstrictor
effects of nocturnal endothelin release and endothelial
dysfunction.
The body mass index (BMI) of OSAHS patients in the pre-
sent study was quite elevated and the obesity had a central dis-
tribution; the waist-hip ratio had a mean ± SD value of 0.91
± 0.08. Also, elevated body mass indices in patients with tach-
yarrhythmia and OSAHS had been reported in many studies
[27].
We found that, both BMI and waist-hip ratio showed sta-
tistically signiﬁcant direct correlation with the severity of
OSAHS as assessed by AHI and oxygen desaturation index
(ODI 3%). Similarly, Peppard and colleagues [38] demon-
strated that BMI is a signiﬁcant independent predictor of the
degree of oxygen desaturation during obstructive events. Oxy-
gen desaturation (as a consequence of obesity and sleep
apnea), directly or indirectly (by promoting ischemia, sympa-
thetic activation, and inﬂammation) may be an important
mechanistic link to cardiac rhythm disturbance [27].
Frost et al. [39] and Dublin et al. [40] found that risk of AF
rises for about 8% per BMI unit increment. Rosengren et al.
[41] found that BMI gain between age 20 and midlife was
strongly related to subsequent AF occurrence in men.
In the present study, BMI had statistically signiﬁcant direct
correlation with systolic blood pressure and fasting blood glu-
cose level (r= 0.486, p= 0.010, r= 0.489, p= 0.009 respec-
tively). Also it showed statistically signiﬁcant direct correlation
with serum total cholesterol and serum triglycerides levels
(r= 0.537, p= 0.002, r= 0.517, p= 0.003 respectively). In
accordance with our ﬁndings, many other studies emphasized
that obesity is highly correlated with the other four compo-
nents of metabolic syndrome [42].
In the present study, neck circumference (NC) showed sta-
tistically signiﬁcant direct correlation with the severity of
OSAHS assessed by AHI (r= 0.749, p< 0.0001). Consider-
able amount of published studies have shown that, from all
clinical predictors, neck circumference is the strongest anthro-
pometric predictor of OSAHS severity followed by waist cir-
cumference or W–H ratio as an indicator of central
distribution of obesity. Neck Circumference-Height Ratio
(NHR) was suggested recently to be included as a simple
screening tool for OSA in children and adults, which along
with other predictors, may improve the ability of clinicians
to triage children and adults at risk for OSA for further eval-
uation with PSG [43].
In the present study, dyslipidemia was a common ﬁnding in
OSAHS patients. 18 out of 27 patients (60%) had hypercholes-
terolemia and 21 (70%) had hypertriglceridemia. Total choles-Please cite this article in press as: S. Mourad et al., Occurrence of sleep related breat
Egypt. J. Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.005terol and triglyceride showed statistically signiﬁcant direct
correlation with the severity of OSAHS as assessed by AHI.
Dyslipidemia may indirectly promote AF due to its athero-
genic complications. [6] Hypercholesterolemia could lead to
temporal, and then permanent, changes in cell membranes of
atrial myocytes by provoking injury of endothelium cells of
atrial muscle microcirculation. These mechanisms may cause
electric remodeling and AF paroxysms. Yet there is no ﬁrm
proof of direct interdependence [6]. In a study by Watanabe
et al., [44] low HDL-cholesterol level (<40 mg/dl in men and
<50 mg/dl in women) was found to be a risk factor for AF
(HR= 1.52; 95% CI = 1.09–2.14). No signiﬁcant relationship
was observed for other atherogenic lipid disturbances. Simi-
larly, neither dyslipidemia nor any of its components were iden-
tiﬁed as AF risk factors in the Framingham population [45].
Combining the components of metabolic syndrome (Met.
S), in the present study, 19 patients (63.3%) had Met.S.
Another ﬁnding is that OSAHS patients with Met.S were
found to have AHI mean ± SD value of 64.4 ± 35.4 compar-
ing to 27.3 ± 9 in OSAHS patients without Met.S.
Trombetta et al. [46] examined how the presence of OSAHS
in patients with metabolic syndrome affected hemodynamic
and autonomic variables associated with poor cardiovascular
outcome and they found that patients with Met.S and comor-
bid OSAHS have higher BP, higher sympathetic drive, and
diminished baroreceptor reﬂex, compared with patients with
Met.S without OSAHS. These adverse cardiovascular and
autonomic consequences of OSAHS may be associated with
poorer outcomes in these patients [46].
Watanabe et al. [44] concluded that metabolic syndrome is
associated with increased risk of AF. The mechanisms by
which Met.S increases the risk of AF are multifactorial includ-
ing inﬂammation and oxidative stress (C-reactive proteins)
have been implicated in the pathogenesis of AF [44–46]. Low
HDL cholesterol was strongly associated with the risk of AF
[44]. Mechanical stress including structural remodeling and
electrophysiological remodeling are critical for AF to perpetu-
ate [44,46].
Finally, the present study offers some important insights
about the importance of considering sleep study for patients
with tachyarrhythmia. Multiple regression analysis was used
to develop a model to predict the presence of OSAHS in
patients with tachyarrhythmia. Each of the predictor variables
entered in the multiple regression analysis had a signiﬁcance of
p< 0.01. We adopted three models of which model ‘‘3” (BMI
+ NC+ serum triglycerides) yielded the highest predictive
value (r2 = 0.886, adjusted r2 = 0.871, std error = 9.83). Mul-
tiple regression analysis results suggest that patients with tach-
yarrhythmia who have higher BMI, NC and triglycerides
values are more likely to have underlying OSAHS.
Conclusion
OSAHS is highly prevalent in patients with tachyarrhythmia.
High triglyceride, NC and BMI are the most predictors of
presence of OSAHS. AF is the most common form of the
arrhythmia in patients with OSAHS. OSAHS should be con-
sidered as part of the workup of patients with tachyarrhyth-
mia. Both clinical apnea score and STOP BANG are good
screening questionnaire to choose patients who need sleep
study.hing disorders in Egyptian patients with tachyarrhythmia without heart failure,
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